Skip to main content

Table 1 Study design

From: The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial

Groups

Vaccination schedule

1st vaccination (month 1)

2nd vaccination (month 2)

3rd vaccination

Group 1

JE vaccination

JE vaccination

Yellow fever vaccination 1 month after second JE vaccine

Group 2

JE vaccination

JE vaccination

Yellow fever vaccination 4 months after second JE vaccine

Group 3

JE vaccination

JE vaccination

Yellow fever vaccination 9 months after second JE vaccine

Group 4

Yellow fever vaccination

No vaccination

No vaccination

  1. JE, Japanese encephalitis.
Back to article page

Trials

ISSN: 1745-6215